Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Clearpoint Neuro Inc
CLPTCurrent price
11.24 USD
-0.76 USD (-6.33%)
Last closed
10.95 USD
Company
www.clearpointneuro.com
ISIN
US18507C1036
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
321 489 888 USD
Yield for 12 month
+127.53 %
1Y
3Y
5Y
10Y
15Y
CLPT
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California. Address: 120 S. Sierra Avenue, Solana Beach, CA, United States, 92075
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
16.33 USDP/E ratio
–Dividend Yield
–Current Year
+23 955 000 USD
Last Year
+20 551 000 USD
Current Quarter
+7 858 000 USD
Last Quarter
+7 639 000 USD
Current Year
+13 614 000 USD
Last Year
+13 531 000 USD
Current Quarter
+4 988 000 USD
Last Quarter
+4 525 000 USD
Key Figures CLPT
1 year
3 years
5 years
10 years
EBITDA
-17 756 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-23.17 %
PEG Ratio
–
Return On Equity TTM
-60.4 %
Wall Street Target Price
16.33 USD
Revenue TTM
28 069 000 USD
Book Value
0.86 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
32.1 %
Dividend Yield
–
Gross Profit TTM
13 531 000 USD
Earnings per share
-0.7 USD
Diluted Eps TTM
-0.7 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-64.06 %
Dividend Analytics CLPT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CLPT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:40
Payout Ratio
–
Last Split Date
27.07.2016
Dividend Date
27.07.2016
Stock Valuation CLPT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
10.7749
Price Sales TTM
11.4536
Enterprise Value EBITDA
-7.0678
Price Book MRQ
10.0053
Financials CLPT
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CLPT
For 52 weeks
4.69 USD
14.13 USD
50 Day MA
12.14 USD
Shares Short Prior Month
618 476
200 Day MA
8.2 USD
Short Ratio
4.23
Shares Short
712 158
Short Percent
2.65 %
BeatStart